Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07124546 · ClinicalTrials.gov registry record · NA
Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers
A NA study of Malignant Hepatobiliary Neoplasm, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07124546 is a NA study of Malignant Hepatobiliary Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07124546, a NA study of Malignant Hepatobiliary Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Acceptance and Commitment Therapy
- OTHER Telemedicine
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2027-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07124546
The ClinicalTrials.gov registry entry for NCT07124546 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Hepatobiliary Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT07124546 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07124546 about?
NCT07124546 is a clinical study titled "Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers". This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behav...
What is the current status of trial NCT07124546?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-28. Estimated completion is 2027-05-30.
What conditions does trial NCT07124546 study?
This clinical trial studies the following conditions: Malignant Hepatobiliary Neoplasm.
What interventions are being tested in trial NCT07124546?
The interventions under investigation include: Questionnaire Administration (OTHER), Acceptance and Commitment Therapy (BEHAVIORAL), Telemedicine (OTHER).
Who is sponsoring clinical trial NCT07124546?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07124546 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Hepatobiliary Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.